Alrijne Zorggroep Stichting — Clinical Trial Site

35 Registered trials

17 Currently recruiting

Organisation

Alrijne Zorggroep Stichting

Location

Leiderdorp, Netherlands

Identifier

ORG-100044549

Address

Simon Smitweg 1, 2353 GA, Netherlands

Departments

#3718: Cardiology
2600:Cardiology
3023: Neurology
3718: Cardiology
Alrijne
Alrijne Ziekenhuis, locatie Leiderdorp Otorhinolaryngology
Cardiology
Department of Internal Medicine
Hematology
Internal medicine
Interne Geneeskunde
Medische Oncologie
Neurology
Oncology
Orthopedic surgery
Orthopedics
Otorhinolaryngology
Research Cardiology Alrijne
Sports medicine
Surgery
Vakgroep Maag-, darm- en leverziekten
Vascular Surgery

Clinical trials at this site (35)

Search interface

LIBREXIA-AF A Phase 3 Active-controlled Study of Milvexian for Prevention of Cardioembolic Events in Participants with Atrial Fibrillation Ended

2022-501419-15-00 Atrial Fibrillation 5 2023-08-23
OCEAN(a)-Outcomes – Olpasiran trials of Cardiovascular Events And LipoproteiN(a) reduction – Outcomes trial Ended

2022-501608-85-00 Cardiovascular disease (atherosclerotic cardiovascular 5 2023-05-09
Noisy Rebels; Non-inferiority study of rituximab compared to ocrelizumab in relapsing MS Ended

2022-502664-21-00 multiple sclerosis 6 2023-05-01
Personalized dosing of ocrelizumab in MS Ended

2024-513193-22-00 Multiple Sclerosis 11 2022-03-16
A research study to find out whether a medicine called inclisiran helps to prevent cardiovascular death, heart attacks or strokes in people … Ended

2024-510735-21-00 Atherosclerotic cardiovascular disease (ASCVD) 5 2021-11-26
A phase 3 multicentre, randomized, prospective, open-label trial of Ibrutinib monotherapy versus fixed-duration Venetoclax plus Obinutuzumab… Ended

2022-500439-35-00 treatment-naive chronic lymphocytic leukemia 5 2021-02-11
A multicenter trial assessing the impact of lipoprotein (a) lowering with pelacarsen (TQJ230) on major cardiovascular events in patients wit… Ended

2023-508292-37-00 Cardiovascular Disease 5 2020-03-06
Endocrine therapy plus CDK 4/6 inhibition in first- or second-line for hormone receptor positive advanced breast cancer - the SONIA study Ended

2024-516204-42-00 Breast cancer 5 2017-11-21
A Phase III double-blind placebo-controlled Randomised Trial of Aspirin on Recurrence and Survival in Colon Cancer Patients Ended

2022-502324-48-00 Patients with resected colon carcinoma 5 2014-08-05
A large global trial to evaluate the efficacy and safety of milvexian in reducing recurrent cardiovascular events in patients after a heart … Ended

2022-501418-69-00 Acute Coronary Syndrome 5 2023-11-21
DIONYSIUS Ended

2024-511743-26-00 Symptomatic Ischemic Ulcer related to Diabetes 6